Data · dataset · 2026
<p><i>NOXA</i> KO restores cellular viability and decreases apoptosis during <i>MARCH5</i> KO.</p>
Listed in UCL Research Data Repository
<p>A. Workflow of the characterization experiments of the <i>NOXA-MARCHF5</i> double KO (DKO) BC-1 Cas9 cells.
Description
Cells were transduced with a lentivirus encoding the targeting gRNA (SAFE4501 or <i>NOXA</i> g1), an eGFP reporter, and puromycin resistance gene (puro<sup>R</sup>). After selection and confirmation of <i>NOXA</i> KO by Western blotting (panel B), these cells were transduced with a second lentivirus encoding another targeting gRNA (g<i>AAVS1</i>, <i>MARCHF5</i> g2 or g3) and the hygromycin resistance gene (hyg<sup>R</sup>).
After 7 days of selection (200 µg/mL) and confirmation of <i>NOXA</i> KO by Western blotting (panel C), cell densities were adjusted to 4 x 10<sup>5</sup> cells/mL and seeded for CellTiter-Glo2.0 Assay, Caspase-Glo 3/7 Assay and FCA for 2 days. B. Western blot of NOXA in SAFE4501 or <i>NOXA</i> g1 cells. C. Western blot of NOXA in <i>MARCHF5</i>-<i>NOXA</i> DKO cells.
Read the rest (2 more)
D-F. DKO cells were characterized using D. CellTiter-Glo2.0 (viability), <b><i>E</i></b>. Caspase-Glo 3/7 Assay (caspase 3/7 activity), or F. FCA (fitness). Caspase-Glo3/7 luminescence signals were normalized to CellTiter-Glo2.0 signals to normalize for total viable cells.
All data in panels D-F, were further normalized to the SAFE4501-g<i>AAVS1</i> DKO cells to establish the baseline. Statistical differences were calculated using one-way ANOVA with Dunnett’s multiple comparison post-hoc test (n = 3). Error bars, standard error of the mean.</p>
Links
Where it is published
- DOI doi.org/10.1371/journal.ppat.1014665.g009 ↗
DOI / persistent id · from rdr ucl ac uk
Catalogue records · 1
- OAI-PMH record api.figshare.com/v2/oai?verb=GetRecord&metadataPrefix=oai_dc&identifier=oai%3Af… ↗
metadata API · from rdr ucl ac uk
Topics
- From keywords
- Biochemistry and cell biology · Cancer · Earth & Environmental Science · Genetics · Infectious diseases · Life Sciences · Medicine & Health · Virology
Provenance · 1 source records, 13 field assertions
| Source | Key | Last seen | Raw |
|---|---|---|---|
| UCL Research Data Repository | oai:figshare.com:article/34049147 | 12 d ago | JSON v1 |
| Field | Assertion | Extractor | Evidence |
|---|---|---|---|
| access_level | source · rdr ucl ac uk | connector:rdr_ucl_ac_uk@1.0.0 | |
| concepts[disease].local:disease:cancer | mapping · rdr ucl ac uk | vocabulary-mapper@1.0.0 | keywords['Cancer'] |
| concepts[field].anzsrc:field:310706 | mapping · rdr ucl ac uk | vocabulary-mapper@1.0.0 | keywords['Virology'] |
| concepts[field].anzsrc:field:320211 | mapping · rdr ucl ac uk | vocabulary-mapper@1.0.0 | keywords['Infectious Diseases'] |
| concepts[field].anzsrc:group:3101 | mapping · rdr ucl ac uk | vocabulary-mapper@1.0.0 | keywords['Cell Biology'] |
| concepts[field].anzsrc:group:3105 | mapping · rdr ucl ac uk | vocabulary-mapper@1.0.0 | keywords['Genetics'] |
| concepts[field].local:field:earth-environmental | mapping · rdr ucl ac uk | connector:rdr_ucl_ac_uk@1.0.0 | |
| concepts[field].local:field:life-sciences | mapping · rdr ucl ac uk | connector:rdr_ucl_ac_uk@1.0.0 | |
| concepts[field].local:field:medicine-health | mapping · rdr ucl ac uk | connector:rdr_ucl_ac_uk@1.0.0 | |
| description | source · rdr ucl ac uk | connector:rdr_ucl_ac_uk@1.0.0 | /metadata/dc/description |
| license | source · rdr ucl ac uk | connector:rdr_ucl_ac_uk@1.0.0 | /metadata/dc/rights |
| publication_date | source · rdr ucl ac uk | connector:rdr_ucl_ac_uk@1.0.0 | |
| title | source · rdr ucl ac uk | connector:rdr_ucl_ac_uk@1.0.0 | /metadata/dc/title |